Regulations.gov document
Exhibit K FDA Guidance Document on Bioavavailability and Bioequivalence Studies for Orally…
Supporting & Related Material · FDA-2014-P-0407 · posted May 28, 2014
Key facts
| Document ID | FDA-2014-P-0407-0006 |
|---|---|
| Title | Exhibit K FDA Guidance Document on Bioavavailability and Bioequivalence Studies for Orally Administered Drug Products Supplement from Almatica Pharma Inc |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2014-P-0407 |
| Posted | May 28, 2014 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: